ASP Isotopes (ASPI) Projected to Post Earnings on Friday

ASP Isotopes (NASDAQ:ASPI) is projected to issue its Q1 2026 results after the market closes on Friday, May 15th. Analysts expect the company to announce earnings of ($0.28) per share and revenue of $3.6760 million for the quarter. Parties can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 21, 2026 at 4:00 PM ET.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Friday, April 10th. The company reported ($0.84) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.70). ASP Isotopes had a negative net margin of 734.14% and a negative return on equity of 161.55%. The firm had revenue of $33.32 million for the quarter, compared to analysts’ expectations of $2.03 million.

ASP Isotopes Stock Performance

Shares of ASP Isotopes stock opened at $5.97 on Wednesday. The business has a 50-day moving average of $5.06 and a 200 day moving average of $6.19. ASP Isotopes has a 12 month low of $3.92 and a 12 month high of $14.49. The stock has a market capitalization of $751.62 million, a price-to-earnings ratio of -2.79 and a beta of 3.26. The company has a debt-to-equity ratio of 0.77, a current ratio of 12.23 and a quick ratio of 12.20.

Analysts Set New Price Targets

ASPI has been the subject of a number of research analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Canaccord Genuity Group restated a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $13.00.

Insider Activity

In other ASP Isotopes news, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52. Following the transaction, the chief financial officer owned 709,376 shares of the company’s stock, valued at $3,887,380.48. The trade was a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Duncan Moore sold 11,642 shares of the business’s stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $5.21, for a total value of $60,654.82. Following the completion of the transaction, the director directly owned 1,044,928 shares in the company, valued at approximately $5,444,074.88. The trade was a 1.10% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 90,704 shares of company stock worth $463,252. 14.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Alyeska Investment Group L.P. grew its position in ASP Isotopes by 73.4% during the fourth quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock worth $26,191,000 after buying an additional 2,072,851 shares during the period. Vanguard Group Inc. grew its holdings in ASP Isotopes by 37.9% in the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after purchasing an additional 1,241,024 shares during the last quarter. Geode Capital Management LLC grew its holdings in ASP Isotopes by 28.0% in the fourth quarter. Geode Capital Management LLC now owns 2,384,066 shares of the company’s stock valued at $12,758,000 after purchasing an additional 521,611 shares during the last quarter. State Street Corp grew its holdings in ASP Isotopes by 31.2% in the fourth quarter. State Street Corp now owns 1,844,405 shares of the company’s stock valued at $9,868,000 after purchasing an additional 438,673 shares during the last quarter. Finally, Marshall Wace LLP grew its holdings in ASP Isotopes by 3,669.1% in the third quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock valued at $12,305,000 after purchasing an additional 1,245,184 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.